No-reflow after stroke reperfusion therapy: An emerging phenomenon to be explored.
Milan JiaFeiyang JinSijie LiChanghong RenMangal RuchiYuchuan DingWenbo ZhaoXun-Ming JiPublished in: CNS neuroscience & therapeutics (2024)
In the field of stroke thrombectomy, ineffective clinical and angiographic reperfusion after successful recanalization has drawn attention. Partial or complete microcirculatory reperfusion failure after the achievement of full patency of a former obstructed large vessel, known as the "no-reflow phenomenon" or "microvascular obstruction," was first reported in the 1960s and was later detected in both experimental models and patients with stroke. The no-reflow phenomenon (NRP) was reported to result from intraluminal occlusions formed by blood components and extraluminal constriction exerted by the surrounding structures of the vessel wall. More recently, an emerging number of clinical studies have estimated the prevalence of the NRP in stroke patients following reperfusion therapy, ranging from 3.3% to 63% depending on its evaluation methods or study population. Studies also demonstrated its detrimental effects on infarction progress and neurological outcomes. In this review, we discuss the research advances, underlying pathogenesis, diagnostic techniques, and management approaches concerning the no-reflow phenomenon in the stroke population to provide a comprehensive understanding of this phenomenon and offer references for future investigations.
Keyphrases
- cerebral ischemia
- subarachnoid hemorrhage
- acute ischemic stroke
- blood brain barrier
- acute myocardial infarction
- atrial fibrillation
- brain injury
- risk factors
- heart failure
- working memory
- high resolution
- spinal cord injury
- percutaneous coronary intervention
- type diabetes
- coronary artery disease
- metabolic syndrome
- mass spectrometry
- mesenchymal stem cells
- middle cerebral artery
- left ventricular
- spinal cord
- case control
- replacement therapy
- chemotherapy induced